Gabelli Funds’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-192,100
Closed -$2.1M 1164
2017
Q2
$2.1M Buy
192,100
+178,100
+1,272% +$1.95M 0.01% 761
2017
Q1
$148K Hold
14,000
﹤0.01% 1109
2016
Q4
$118K Hold
14,000
﹤0.01% 1120
2016
Q3
$100K Hold
14,000
﹤0.01% 1143
2016
Q2
$108K Hold
14,000
﹤0.01% 1144
2016
Q1
$102K Hold
14,000
﹤0.01% 1112
2015
Q4
$108K Hold
14,000
﹤0.01% 1114
2015
Q3
$100K Hold
14,000
﹤0.01% 1071
2015
Q2
$149K Hold
14,000
﹤0.01% 1063
2015
Q1
$173K Hold
14,000
﹤0.01% 1045
2014
Q4
$131K Hold
14,000
﹤0.01% 1070
2014
Q3
$140K Hold
14,000
﹤0.01% 1071
2014
Q2
$144K Hold
14,000
﹤0.01% 1053
2014
Q1
$174K Hold
14,000
﹤0.01% 1033
2013
Q4
$172K Hold
14,000
﹤0.01% 1026
2013
Q3
$121K Hold
14,000
﹤0.01% 1023
2013
Q2
$122K Buy
+14,000
New +$125K ﹤0.01% 1020

Other funds holding ELOS

Gabelli Funds's ELOS Position: Q3 2017 in Review

Gabelli Funds sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 192,100 shares — an estimated $2.1M sold.

Gabelli Funds first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $2.1M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Gabelli Funds reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Gabelli Funds sold 192,100 Syneron Medical Ltd shares in Q3 2017, an estimated $2.1M.
  • Gabelli Funds first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
  • Gabelli Funds's Syneron Medical Ltd position peaked at $2.1M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Gabelli Funds's 13F filing for Q3 2017, filed 1 Nov 2017.